Advertisement

Topics

American Society of Gene Therapy Company Profile

13:59 EDT 24th September 2018 | BioPortfolio

The American Society of Gene Therapy (ASGT) is a non-profit medical and professional organization that represents researchers and scientists devoted to the discovery of new gene therapies. ASGT was established in 1996 by Dr. George Stamatoyannopoulos, professor of medicine at the University of Washington 's School of Medicine and a group of the country's leading researchers in gene therapy. With more than 2,000 members in the United States and worldwide, ASGT is the largest association of individuals involved in gene therapeutics. The Society's Executive Office is located in Milwaukee, WI.
Governed by its officers and board of directors, ASGT has nine standing committees, including Clinical/Regulatory Affairs, Ethics, Education, Membership, Program, and Public Education and Outreach; and 14 scientific committees that focus on disease-specific issues such as cancer, cardiovascular, genetic, musculo-skeletal, infectious, and neural degenerative disorders.

Location

555 East Wells StreetSuite 1100
Milwaukee
Wisconsin
53202
United States of America

Contact

Phone: 414.278.1341
Fax: 414.276.3349
Email: info@asgt.org


News Articles [4477 Associated News Articles listed on BioPortfolio]

ASGCT Issues White Paper Addressing the Value of Gene Therapy

In advance of the American Society of Gene & Cell Therapy's 21st Annual Meeting, the Society has issued a white paper addressing the issues surrounding value and payment for new and incoming g...

ASGCT Opens Group's Largest-Ever Annual Meeting

The 21st Annual Meeting of the American Society of Gene and Cell Therapy, the first in Chicago and the largest in ASGCT, opens today to more than 3,100 pre-registered attendees to take in nearly 1,000...

2018 ASGCT Annual Meeting Becomes Group's Largest

The 21st Annual Meeting of the American Society of Gene and Cell Therapy grew 31 percent and was the largest in group history. MILWAUKEE (PRWEB) June 05, 2018 The 2018 American Society of Gene and Ce...

Intellia Therapeutics Announces WT1 as Its First Cell Therapy Target, Following Presentation of Early Data at the American Society of Gene and Cell Therapy 21st Annual Meeting

CAMBRIDGE, Mass., May 17, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technolo...

New CAR T case study shows promise in acute myeloid leukaemia

Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy util...

Voyager Therapeutics Announces New Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

VY-SOD101 achieves meaningful suppression of disease-causing gene of ALS in large mammals after a one-time administration Results during the second half of 2018 from further delivery optimization e...

Top-Rated Research to be Presented Today at ASGCT

The American Society of Gene & Cell Therapy hosts the presentation of the top-rated abstracts as part of today's Presidential Symposium at the 21st Annual Meeting. Chicago (PRWEB) May 18, 2018...

Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

Voyager’s gene therapy vector for Friedreich’s ataxia prevents central and peripheral disease progression in preclinical model out to one year after a single administration Durable safety data ...

Clinical Trials [5035 Associated Clinical Trials listed on BioPortfolio]

Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients

The American Society of Clinical Oncology (ASCO) and the /College of American Pathologists (CAP) recommend that HER2 status (negative or positive) must be determined in all patients with i...

Postoperative Cognitive Dysfunction After Propofol Anesthesia for Noncardiac Surgery

Background: Postoperative cognitive dysfunction (POCD) in elderly patients after noncardiac surgery is a common problem. Therefore,this study was designed to assess POCD after closed-loop...

RGX-111 Gene Therapy in Patients With MPS I

RGX-111 is a gene therapy which is intended to deliver a functional copy of the α-L-iduronidase (IDUA) gene to the central nervous system. This is a safety and dose ranging study to deter...

Gene Therapy in Treating Patients With Cancer of The Liver

RATIONALE: Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy with the p5...

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

OBJECTIVES: I. Develop an approach for treating patients with homozygous familial hypercholesterolemia using gene therapy with autologous hepatocytes transduced with a normal low-density...

Companies [2930 Associated Companies listed on BioPortfolio]

American Society of Gene Therapy

The American Society of Gene Therapy (ASGT) is a non-profit medical and professional organization that represents researchers and scientists devoted to the discovery of new gene therapies. ASGT was es...

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology re...

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is ...

Federation of american societes for Expermental biology

Founded in 1912 by three societies, FASEB has consistently provided educational meetings and publications to disseminate biological research results. The then six Member Societies met in 1989 to alt...

Neurologix

Neurologix, Inc., a leader in the development of innovative therapies for the brain and central nervous system, utilizes gene therapy and other novel technologies. The central nervous system ("CNS") i...

More Information about "American Society of Gene Therapy" on BioPortfolio

We have published hundreds of American Society of Gene Therapy news stories on BioPortfolio along with dozens of American Society of Gene Therapy Clinical Trials and PubMed Articles about American Society of Gene Therapy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of American Society of Gene Therapy Companies in our database. You can also find out about relevant American Society of Gene Therapy Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record